Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Catalytic isoforms of AMP-activated protein kinase differentially regulate IMPDH activity and photoreceptor neuron function
Tae Jun Lee, … , Andrea Santeford, Rajendra S. Apte
Tae Jun Lee, … , Andrea Santeford, Rajendra S. Apte
Published January 16, 2024
Citation Information: JCI Insight. 2024;9(4):e173707. https://doi.org/10.1172/jci.insight.173707.
View: Text | PDF
Research Article Metabolism Ophthalmology

Catalytic isoforms of AMP-activated protein kinase differentially regulate IMPDH activity and photoreceptor neuron function

  • Text
  • PDF
Abstract

AMP-activated protein kinase (AMPK) plays a crucial role in maintaining ATP homeostasis in photoreceptor neurons. AMPK is a heterotrimeric protein consisting of α, β, and γ subunits. The independent functions of the 2 isoforms of the catalytic α subunit, PRKAA1 and PRKAA2, are uncharacterized in specialized neurons, such as photoreceptors. Here, we demonstrate in mice that rod photoreceptors lacking PRKAA2, but not PRKAA1, showed altered levels of cGMP, GTP, and ATP, suggesting isoform-specific regulation of photoreceptor metabolism. Furthermore, PRKAA2-deficient mice displayed visual functional deficits on electroretinography and photoreceptor outer segment structural abnormalities on transmission electron microscopy consistent with neuronal dysfunction, but not neurodegeneration. Phosphoproteomics identified inosine monophosphate dehydrogenase (IMPDH) as a molecular driver of PRKAA2-specific photoreceptor dysfunction, and inhibition of IMPDH improved visual function in Prkaa2 rod photoreceptor–knockout mice. These findings highlight a therapeutically targetable PRKAA2 isoform–specific function of AMPK in regulating photoreceptor metabolism and function through a potentially previously uncharacterized mechanism affecting IMPDH activity.

Authors

Tae Jun Lee, Yo Sasaki, Philip A. Ruzycki, Norimitsu Ban, Joseph B. Lin, Hung-Ting Wu, Andrea Santeford, Rajendra S. Apte

×

Figure 3

Prkaa2-Rhod/-Rhod retinas demonstrate phospho-purine overproduction and increased glycolysis.

Options: View larger image (or click on image) Download as PowerPoint

Prkaa2-Rhod/-Rhod retinas demonstrate phospho-purine overproduction and...
(A–H) Metabolomics analyses of different phospho-purines in Prkaa2-Rhod/-Rhod retinas using LC-MS/MS (n = 9). (A) Prkaa2-Rhod/-Rhod retinas demonstrated near-significant increase in cGMP levels, a critical regulator of the dark current (P = 0.056 by Welch’s t test). (B and C) GMP and GDP levels were not significantly changed in Prkaa2-Rhod/-Rhod. (D) GTP levels were significantly increased in Prkaa2-Rhod/-Rhod (**P < 0.01 by Welch’s t test). (E) Levels of IMP, a precursor to GMP, were not significantly changed in Prkaa2-Rhod/-Rhod. (F and G) AMP and ADP levels were not significantly changed in Prkaa2-Rhod/-Rhod. (H) ATP levels were significantly increased in Prkaa2-Rhod/-Rhod (**P < 0.01 by Welch’s t test). (I and J) Extracellular flux analyses by retina Seahorse of Prkaa2-Rhod/-Rhod. (I) Oxygen consumption rate as a measure of oxidative phosphorylative flux was not significantly changed in Prkaa2-Rhod/-Rhod (n = 7). (J) Extracellular acidification rate as a measure of glycolytic flux was significantly increased (P < 0.0001 by 2-way ANOVA, comparing the wild-type group to the knockout group as a whole). Glycolysis (*P < 0.05, **P < 0.01 by post hoc Bonferroni’s multiple comparisons test) and glycolytic capacity (***P < 0.001 by post hoc Bonferroni’s multiple comparisons test) were significantly upregulated in Prkaa2-Rhod/-Rhod (n = 8). (K) Excreted retina lactate levels were significantly increased in Prkaa2-Rhod/-Rhod, supporting the increased glycolysis phenotype (n = 7, *P < 0.05 by Welch’s t test). Values are mean ± SEM.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts